Cargando…
Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
Dose escalation is key for improved outcomes in intermediate‐risk prostate cancer, including unfavorable intermediate‐risk (UIR) cases. This educational report is designed to provide information about our quality high‐dose (125)I seed implantation monotherapy technique in which a biologically effect...
Autor principal: | Okamoto, Keisei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200501/ https://www.ncbi.nlm.nih.gov/pubmed/33939267 http://dx.doi.org/10.1002/acm2.13224 |
Ejemplares similares
-
A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019) -
The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011) -
Biological effective dose in analysis of rectal dose in prostate cancer patients who underwent a combination therapy of VMAT and LDR with hydrogel spacer insertion
por: Zhang, Honglai, et al.
Publicado: (2022) -
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020) -
Dosimetric parameters of three new solid core I‐125 brachytherapy sources
por: Solberg, Timothy D., et al.
Publicado: (2002)